These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 858916

  • 21. Phagocytosis of concanavalin A-treated erythrocytes is mediated by the Fc gamma receptor.
    Salmon JE, Kimberly RP.
    J Immunol; 1986 Jul 15; 137(2):456-62. PubMed ID: 2941482
    [Abstract] [Full Text] [Related]

  • 22. Effect of concanavalin A on the functional activity of hemolytic antibody.
    Langone JJ, Boyle MD, Borsos T.
    Immunol Commun; 1977 Jul 15; 6(3):283-96. PubMed ID: 885582
    [Abstract] [Full Text] [Related]

  • 23. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD, Frank MM.
    J Clin Invest; 1972 Mar 15; 51(3):583-9. PubMed ID: 4622104
    [Abstract] [Full Text] [Related]

  • 24. New methods for the preparation of the cellular intermediate EAC14.
    Asghar SS, Out J.
    J Immunol Methods; 1986 Dec 24; 95(2):277-81. PubMed ID: 3794347
    [Abstract] [Full Text] [Related]

  • 25. Functional and biochemical properties of the early classical complement system of mice.
    Goldman MB, Bangalore S, Goldman JN.
    J Immunol; 1978 Jan 24; 120(1):216-24. PubMed ID: 627718
    [Abstract] [Full Text] [Related]

  • 26. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 24; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 27. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A, Walter W, Teshima H, Boumsell L, Good RA, Day NK.
    J Immunol; 1976 Oct 24; 117(4):1117-26. PubMed ID: 977945
    [Abstract] [Full Text] [Related]

  • 28. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA, Ruiz-Gómez G, Le GT, Abbenante G, Fairlie DP.
    Biochemistry; 2009 Sep 08; 48(35):8466-72. PubMed ID: 19642650
    [Abstract] [Full Text] [Related]

  • 29. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB, Prichard-Thomas S, Lachmann PJ, Coombs RR.
    Immunology; 1980 Feb 08; 39(2):195-202. PubMed ID: 7380467
    [Abstract] [Full Text] [Related]

  • 30. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
    Laham MN, Caldwell JR, Panush RS.
    J Clin Lab Immunol; 1982 Oct 08; 9(1):39-47. PubMed ID: 6983586
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of complement-mediated lysis of sheep erythrocytes by cell-free preparations from Streptococcus mutans BHT.
    Silvestri LJ, Knox KW, Wicken AJ, Hoffmann EM.
    J Immunol; 1979 Jan 08; 122(1):54-60. PubMed ID: 570205
    [Abstract] [Full Text] [Related]

  • 32. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins.
    Smirnova IV, Khaspekova SG, Ignatov VV, Mazurov AV.
    Biochemistry (Mosc); 1998 Jun 08; 63(6):710-8. PubMed ID: 9668212
    [Abstract] [Full Text] [Related]

  • 33. Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharide.
    Schultz DR, Loos M, Bub F, Arnold PI.
    J Immunol; 1980 Mar 08; 124(3):1251-7. PubMed ID: 7358983
    [No Abstract] [Full Text] [Related]

  • 34. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
    Couderc J, Kazatchkine MD, Ventura M, Duc HT, Maillet F, Thobie N, Liacopoulos P.
    J Immunol; 1985 Jan 08; 134(1):486-91. PubMed ID: 3917282
    [Abstract] [Full Text] [Related]

  • 35. T lymphocyte-mediated cytolysis. III. Delineation of mechanisms whereby mitogenic and non-mitogenic lectins mediate lymphocyte-target interaction.
    Berke G, Rosen D, Moscovitch M.
    Immunology; 1983 Aug 08; 49(4):585-92. PubMed ID: 6603417
    [Abstract] [Full Text] [Related]

  • 36. Characterization of mouse helper and suppressor T cell subsets separated by lectins.
    Nakano T, Imai Y, Naiki M, Osawa T.
    J Immunol; 1980 Nov 08; 125(5):1928-32. PubMed ID: 7000893
    [Abstract] [Full Text] [Related]

  • 37. Complement fixation by rheumatoid factor.
    Tanimoto K, Cooper NR, Johnson JS, Vaughan JH.
    J Clin Invest; 1975 Mar 08; 55(3):437-45. PubMed ID: 1078825
    [Abstract] [Full Text] [Related]

  • 38. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
    Okada H, Okada N.
    Immunology; 1975 Jun 08; 28(6):1165-71. PubMed ID: 1169221
    [Abstract] [Full Text] [Related]

  • 39. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
    Cortens M, Sklar S, Richter M.
    Immunology; 1980 Nov 08; 41(3):623-34. PubMed ID: 7461704
    [Abstract] [Full Text] [Related]

  • 40. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ, Kasper DL.
    J Immunol; 1986 Jun 01; 136(11):4157-62. PubMed ID: 3517165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.